Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2024 ▲▼ | Q4 2024 ▲▼ | Change ▲▼ | Q3 2024 ▲▼ | Q4 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| CG Oncology, Inc.COMM(CGON) | 3,670,206 | 3,670,206 | 0 | $138.48M | $105.26M | 10.29% | -$33.22M |
| Dyne Therapeutics, Inc.COMM(DYN) | 2,650,150 | 2,650,150 | 0 | $95.19M | $62.44M | 6.10% | -$32.76M |
| Xencor, Inc.COMM(XNCR) | 2,427,138 | 2,452,138 | +25,000 | $48.81M | $56.35M | 5.51% | +$7.54M |
| Cogent Biosciences, Inc.COMM(COGT) | 6,964,375 | 6,964,375 | 0 | $75.22M | $54.32M | 5.31% | -$20.89M |
| Centessa Pharmaceuticals PlcADRS | 2,890,816 | 2,890,816 | 0 | $46.22M | $48.42M | 4.73% | +$2.20M |
| Ocular Therapeutix, Inc.COMM(OCUL) | 5,319,148 | 5,319,148 | 0 | $46.28M | $45.43M | 4.44% | -$851.1K |
| Upstream Bio, Inc.COMM(UPB) | 0 | 2,801,763 | +2,801,763 | $0 | $44.86M | 4.38% | +$44.86M |
| ABIVAX Société AnonymeADRS(ABVX) | 6,056,596 | 6,056,596 | 0 | $69.77M | $44.33M | 4.33% | -$25.44M |
| Savara Inc.COMM(SVRA) | 12,362,205 | 12,362,205 | 0 | $52.42M | $37.95M | 3.71% | -$14.46M |
| Tango Therapeutics, Inc.COMM(TNGX) | 0 | 10,736,000 | +10,736,000 | $0 | $33.17M | 3.24% | +$33.17M |
| Dianthus Therapeutics, Inc.COMM(DNTH) | 0 | 1,501,624 | +1,501,624 | $0 | $32.74M | 3.20% | +$32.74M |
| Disc Medicine, Inc.COMM(IRON) | 486,957 | 486,957 | 0 | $23.93M | $30.87M | 3.02% | +$6.94M |
| Mineralys Therapeutics, Inc.COMM(MLYS) | 2,470,265 | 2,470,265 | 0 | $29.91M | $30.41M | 2.97% | +$494.1K |
| Tourmaline Bio IncCOMM | 1,477,593 | 1,477,593 | 0 | $37.99M | $29.97M | 2.93% | -$8.02M |
| Structure Therapeutics IncADRS | 1,063,000 | 1,063,000 | 0 | $46.66M | $28.83M | 2.82% | -$17.83M |
| Tyra Biosciences, Inc.COMM(TYRA) | 1,989,103 | 1,989,103 | 0 | $46.76M | $27.65M | 2.70% | -$19.12M |
| EyePoint, Inc.COMM(EYPT) | 922,335 | 3,572,335 | +2,650,000 | $7.37M | $26.61M | 2.60% | +$19.24M |
| Cidara Therapeutics, Inc.COMM | 0 | 1,005,901 | +1,005,901 | $0 | $26.09M | 2.55% | +$26.09M |
| Third Harmonic Bio IncCOMM | 2,415,000 | 2,505,424 | +90,424 | $32.72M | $25.78M | 2.52% | -$6.94M |
| Soleno Therapeutics IncCOMM | 550,000 | 550,000 | 0 | $27.77M | $24.72M | 2.42% | -$3.05M |
| Astria Therapeutics IncCOMM | 2,761,861 | 2,761,861 | 0 | $30.41M | $24.69M | 2.41% | -$5.72M |
| Fulcrum Therapeutics, Inc.COMM(FULC) | 5,250,000 | 5,250,000 | 0 | $18.74M | $24.68M | 2.41% | +$5.93M |
| Silence Therapeutics plcADRS(SLN) | 3,033,560 | 3,033,560 | 0 | $55.15M | $20.87M | 2.04% | -$34.28M |
| RAPT Therapeutics, Inc.COMM | 0 | 13,135,260 | +13,135,260 | $0 | $19.75M | 1.93% | +$19.75M |
| Amylyx Pharmaceuticals, Inc.COMM(AMLX) | 4,643,812 | 4,643,812 | 0 | $15.05M | $17.55M | 1.72% | +$2.51M |
| COMPASS Pathways plcADRS(CMPS) | 3,858,000 | 3,858,000 | 0 | $24.31M | $14.58M | 1.43% | -$9.72M |
| Kura Oncology, Inc.COMM(KURA) | 1,423,642 | 1,423,642 | 0 | $27.82M | $12.40M | 1.21% | -$15.42M |
| MBX Biosciences, Inc.COMM(MBX) | 650,000 | 650,000 | 0 | $16.89M | $11.98M | 1.17% | -$4.91M |
| Kodiak Sciences Inc.COMM(KOD) | 1,008,158 | 1,145,538 | +137,380 | $2.63M | $11.40M | 1.11% | +$8.77M |
| Entrada Therapeutics, Inc.COMM(TRDA) | 584,955 | 584,955 | 0 | $9.35M | $10.11M | 0.99% | +$766.3K |
| Keros Therapeutics, Inc.COMM(KROS) | 879,344 | 550,000 | -329,344 | $51.06M | $8.71M | 0.85% | -$42.36M |
| Adverum Biotechnologies IncCOMM | 2,008,339 | 1,796,482 | -211,857 | $14.10M | $8.39M | 0.82% | -$5.71M |
| Vistagen Therapeutics, Inc.COMM(VTGN) | 2,676,580 | 2,676,580 | 0 | $8.06M | $7.90M | 0.77% | -$160.6K |
| Aerovate Therapeutics IncCOMM | 2,240,809 | 2,240,809 | 0 | $4.68M | $5.94M | 0.58% | +$1.25M |
| Nektar TherapeuticsCOMM(NKTR) | 4,000,000 | 4,000,000 | 0 | $5.20M | $3.72M | 0.36% | -$1.48M |
| Avalo Therapeutics, Inc.COMM(AVTX) | 483,000 | 483,000 | 0 | $4.59M | $3.59M | 0.35% | -$999.8K |
| Ventyx Biosciences IncCOMM | 316,195 | 316,195 | 0 | $689.3K | $692.5K | 0.07% | +$3.2K |
| Cabaletta Bio, Inc.COMM(CABA) | 86,795 | 86,795 | 0 | $409.7K | $197.0K | 0.02% | -$212.6K |
| AN2 Therapeutics, Inc.COMM | 1,555,118 | 0 | -1,555,118 | $1.66M | $0 | — | -$1.66M |
| Edgewise Therapeutics, Inc.COMM(EWTX) | 2,112,984 | 0 | -2,112,984 | $56.40M | $0 | — | -$56.40M |
| Tarsus Pharmaceuticals, Inc.COMM(TARS) | 231,820 | 0 | -231,820 | $7.62M | $0 | — | -$7.62M |